Navigation Links
Chembio Reports 3rd Quarter 2011 Results
Date:11/3/2011

ct.  During October 2011 we received CE Marking for this product and this is allowing us to start commercializing it outside the United States.

Sure Check HIV for Consumer Self-Testing -- In September 2011, the Company received clarification from the Food and Drug Administration for the regulatory requirements for the Sure Check® HIV 1/2 rapid test for sale over-the-counter (OTC).  Additional studies are required for submission of an Investigational Device Exemption (IDE) as the first step toward product approval.  We believe these studies can be completed by the end of the first quarter of 2012 at which time we would submit our IDE to the FDA.

RESEARCH & DEVELOPMENTDPP® Leptospirosis -- We have approximately nine months left of the three-year $3 million Small Business Innovative Research (SBIR) Phase II grant we were awarded in 2009 by the United States National Institutes of Health (NIH) to fully develop, validate, and commercialize a rapid diagnostic test for Leptospirosis for general use worldwide.  Our work pursuant to this grant is progressing on schedule. The test will be developed with our DPP® technology and will utilize proprietary reagents developed by Yale University and the Oswaldo Cruz Foundation at the Brazilian Ministry of Health.  Development of the test will be in collaboration with the Division of Infectious Diseases, Yale University in New Haven, CT and the Oswaldo Cruz Foundation, the largest biomedical research institution in Latin America.

DPP® Tuberculosis -- As reported in February 2011, we were awarded a three-year $2.9 million, subsequently reduced to $2.4 million, Small Business Innovative Research (SBIR) Phase II grant from the United States National Institutes of Health (NIH) to continue development of a simple, rapid, accurate, and cost-effective serological test for active tuberculosis that can be utilized in resource-limited settings.  '/>"/>

SOURCE Chembio Diagnostics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Chembio to Host Conference Call to Discuss 3rd Quarter 2011 Financial Results
2. Chembio Diagnostics CFO Richard J. Larkin Among the Recipients of "2011 CFO of the Year" Award from Long Island Business News
3. NxStage Reports Record Third Quarter 2011 Financial Results and Raises Revenue Guidance For 2011
4. Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results
5. CVS Caremark Reports Third Quarter Results
6. Onyx Pharmaceuticals Reports Third Quarter 2011 Financial Results
7. Idenix Pharmaceuticals Reports Third Quarter and Nine Month 2011 Financial Results and Provides Pipeline Update
8. Nektar Therapeutics Reports Third Quarter 2011 Financial Results
9. Par Pharmaceutical Companies Reports Third Quarter 2011 Results
10. Luminex Corporation Reports Third Quarter 2011 Results
11. Anthera Pharmaceuticals Reports 2011 Third Quarter Financial Results and Operational Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... TAIPEI , Sept. 1, 2015 ... 2,500 employees, SHL Group has rapidly reached 3,000 ... yet rapid growth in the injectable drug delivery ... A global leader in the design ... SHL offers innovative designs, robust manufacturing capabilities, a ...
(Date:9/1/2015)... Sept. 1, 2015 Pressure BioSciences, Inc. ... in the development and sale of broadly enabling, ... the worldwide life sciences industry, today announced the ... the Company,s PCT Platform could play a significant ... This role is based on PCT,s unique ability ...
(Date:9/1/2015)...  Abbott (NYSE: ABT ) announced today positive one-year ... comparing the safety and effectiveness of Abbott,s fully dissolving ... market-leading, permanent drug eluting stent. The trial was conducted ... and enrolled 400 people with coronary artery disease, the ... be featured at a late-breaking session today at ESC ...
Breaking Medicine Technology:SHL Group Reaches Major Milestone of 3000 Employees 2New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 2New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 3New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 4New Scientific Publication Suggests Pressure BioSciences' PCT Platform Could Play Significant Role in Personalized/Precision Medicine 5Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 2Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 3Abbott Announces Positive Results of Its Naturally Dissolving Stent from ABSORB Japan Study 4
... , NEW YORK, November 17 ... biomarkers will help identify and monitor patients at risk,of developing ... are,cared for in prenatal clinics around the world. , ... highly-respected National,Institute of Child and Human Development of the National ...
... , NEW YORK, Nov. 17 ... Street is the first laser hair removal center in New ... system by Cynosure, Inc., a leading developer and manufacturer of ... Elite MPX, which incorporates Cynosure,s patented MultiPlex sequencing technology, is ...
Cached Medicine Technology:New Study Heralds Use of Blood Biomarkers to Predict Preeclampsia 2New Study Heralds Use of Blood Biomarkers to Predict Preeclampsia 3Romeo and Juliette Laser Hair Removal Is First Center in New York City to Own Cynosure's New Elite MPX(TM) Laser System 2
(Date:9/1/2015)... ... September 01, 2015 , ... Negative pressure wound ... a wound to remove exudates, fluid, and infectious materials to prepare the wound ... devices, disposable devices, and canisters, etc.) is projected to expand continuously through 2021. ...
(Date:9/1/2015)... ... September 01, 2015 , ... Plaza OBGYN in Houston, ... Touch® , an innovative vaginal health laser procedure that prevents and resolves dryness ... for atrophic vaginitis, a condition that causes vaginal dryness, pelvic discomfort, painful intercourse ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... has announced that Edge Information Management has been granted continued accreditation ... Credentialing Council (BSCC). , ÔÇťAchieving and maintaining this accreditation takes the ...
(Date:9/1/2015)... MA (PRWEB) , ... September 01, 2015 , ... ... remote real-time monitoring and analysis of pet vital signs and activity, today announced ... is one of the most popular and widely-adopted veterinary hospital Practice Management Software ...
(Date:9/1/2015)... Francisco, Calif. (PRWEB) , ... September 01, 2015 ... ... to corporations, law firms and government entities, announced today that it has hired ... Senior Discovery Consultant. In this capacity, Sanderson will be responsible for establishing ...
Breaking Medicine News(10 mins):Health News:World Negative Pressure Wound Therapy Market Assessed by GlobalData in In-demand Report Published at MarketPublishers.com 2Health News:World Negative Pressure Wound Therapy Market Assessed by GlobalData in In-demand Report Published at MarketPublishers.com 3Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 2Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 3Health News:Edge Information Management Granted Continued NAPBS Accreditation 2Health News:Edge Information Management Granted Continued NAPBS Accreditation 3Health News:Petpace-Cornerstone Integration Lowers Overhead, Raises Data Visibility for Veterinary Practices 2Health News:Former NFL Standout Scott Sanderson Joins eDiscovery Leader Discovia 2
... mediator in the blood that influences immune cell migration ... between the build-up and breakdown of bones in the ... bone, may provide a new target for scientists developing ... and rheumatoid arthritis. , The study comes ...
... WASHINGTON, Feb. 7 As the military deals with ... of Veterans Affairs Eric K. Shinseki reminded Veterans and ... has an extensive array of services to help Veterans ... take advantage of our suicide-prevention program," said Shinseki. "Help ...
... women who got injections report reduced pain and ... first evidence that gene therapy can ease symptoms in ... American and German researchers. , The study included ... interleukin-1 receptor antagonist (IL-1Ra) gene into the women,s affected ...
... CVD ) today announced that it will present at ... 2009 at 3:30 p.m. (ET). Investors may access a ... In order to register and download any necessary software, please ... Princeton, New Jersey, is one of the world,s largest and ...
... World Heart Corporation,("WorldHeart", Nasdaq: WHRT ), ... has appointed John Alexander ("Alex") Martin as,President and CEO. ... the Board of,Directors. Mr. Martin joins WorldHeart from ... Region and Corporate Vice President since,2004. Previously, Alex ...
... the same as supplement available in U.S., study says , , ... and 6 sulfate (CS) appears to slow the worsening and ease ... , The European study, published in the February issue ... CS over two years lost less joint space -- with few ...
Cached Medicine News:Health News:Scientists discover key factor in controlling the breakdown of bone 2Health News:Scientists discover key factor in controlling the breakdown of bone 3Health News:VA Suicide Prevention Hotline Credited with 2,600 'Saves' 2Health News:Gene Therapy May Ease Rheumatoid Arthritis 2Health News:WorldHeart Appoints New President and CEO 2Health News:WorldHeart Appoints New President and CEO 3
RIA kit for the quantitative determination of autoantibodies to thyroid peroxidase (TPO) in serum....
For the quantitative determination of Estradiol (E2) concentration in human serum or plasma....
... Estradiol (E2) concentration in human serum or plasma. ... a phenolic A ring. This steroid hormone ... is the most potent natural Estrogen, produced mainly ... by the adrenal cortex, and the male testes. ...
... (cTnI) has been useful in the differential ... (ED) with chest pain. 18-20 ... levels of sensitive and specific biomarkers, such ... creatine kinase (CK-MB), and myoglobin, are increased ...
Medicine Products: